VITASPRING BIOMEDICAL CO., LTD. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
VITASPRING BIOMEDICAL CO., LTD. (VSBC) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $217.10 thousand for the 12-month period ending 2022-01-31, per its 10-Q filed 2022-09-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2022-09-15
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|
| 2022-01-31 | $217.10K 10-Q · filed 2022-09-15 |